MCL1 and cancer: High levels of BCL-2 and MCL-1 in drug-resistant BLBC may indicate those cells that are ‘primed for death’ whereby surviving cancer cells with high levels of pro-survival proteins are intrinsically resistant to a wide range of chemotherapeutics, but are, in fact, poised for death when exposed to an agent that competitively antagonizes the elevated pro-survival protein [164].